Neuropacsâ„¢ Corp., an innovator in AI-enabled neurological imaging, today announced that the U.S. Food and Drug Administration has granted De Novo classification to neuropacsâ„¢, a diffusion MRI-based ...
With autism prevalence now reaching 1 in 31 children in the United States according to the latest CDC data, the pressure on ...